Skip to main content
. 2015 Sep 14;33(33):3938–3944. doi: 10.1200/JCO.2015.60.8588

Table A3.

Invasive IBE Rates for Clinically Relevant Subsets of Patients

Variable No. 5 Years
10 Years
12 Years
P
% 95% CI % 95% CI % 95% CI
Age, years
    ≤ 49 106 2.9 0 to 6.2 5.1 0.7 to 9.5 6.4 1.4 to 11.4 .57
    50-69 312 3.4 1.3 to 5.4 6.8 3.8 to 9.7 8.1 4.8 to 11.4
    ≥ 70 143 0.8 0 to 2.4 7.1 2.0 to 12.3 7.1 2.0 to 12.3
Minimum negative margin width, mm
    < 5 203 2.2 0.1 to 4.3 6.3 2.7 to 10.0 6.3 2.7 to 10.0 .46
    5-9 239 3.1 0.8 to 5.4 7.4 3.7 to 11.0 9.4 5.2 to 13.6
    ≥ 10 119 2.7 0 to 5.8 4.7 0.7 to 8.8 6.0 1.3 to 10.7
Tumor size, mm*
    ≤ 5 226 2.3 0.3 to 4.3 4.8 1.9 to 7.8 4.8 1.9 to 7.8 .17
    6-10 231 1.9 0.1 to 3.7 7.9 4.0 to 11.7 10.0 5.5 to 14.5
    > 10 104 5.4 0.8 to 10.0 6.8 1.5 to 12.0 8.5 2.3 to 14.8
CAP grade
    Low 61 1.8 0 to 5.3 5.5 0 to 11.6 5.5 0 to 11.6 .69
    Intermediate 249 2.2 0.3 to 4.1 5.3 2.2 to 8.3 6.6 3.1 to 10.2
    High 110 2.9 0 to 6.2 9.3 3.5 to 15.2 9.3 3.5 to 15.2

NOTE. Analysis restricted to patients enrolled in cohort 1 (n = 561).

Abbreviations: CAP, College of American Pathologists; IBE, ipsilateral breast event.

*

Tumor size was based on central pathology review, when this information was available.

Restricted to the subset of cases for which a central pathology review was performed using current CAP guidelines.